4023 agreement project 01, alphavirus
Other Transaction IDV Awarded Last action
- Contract number
- W911SR2390012
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $62,350,640.00
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
The Joint PEO Chemical and Biological Defense awarded an Other Transaction IDV to Battelle Memorial Institute with a ceiling of $62.35 million on May 16, 2023. This OT IDV operates outside the FAR under statutory authority outside traditional procurement regulations and provides rapid development of medical countermeasures for chemical and biological defense. The agreement covers 4023 AGREEMENT PROJECT 01, ALPHAVIRUS, with a modification that incorporates a project for chemical threats prophylactics.
Battelle, a large nonprofit research and development organization headquartered in Columbus, Ohio, delivers scientific, engineering, and technical services across defense, homeland security, health, and environmental domains. The organization maintains significant relationships with the National Institute of Allergy and Infectious Diseases and related health agencies, providing pre-clinical evaluation services for antiviral drug candidates, vaccine testing support, and animal model development for infectious disease research—core capabilities directly applicable to this medical countermeasures vehicle.
As a multiple-award OT IDV, this agreement establishes a vehicle through which JPEO-CBRND can issue task orders to rapidly prototype and develop pharmaceutical countermeasures to chemical and biological threats. Battelle's existing $136.6 million Evaluation and Testing Services IDV with NIAID for vaccine and biologic testing, extending through September 2035, positions the contractor to execute prototype development and validation work under this vehicle with established laboratory and testing infrastructure.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $900,000 | |
| Supplemental Agreement for work within scope | $6,056,137 | |
| Funding Only Action | $1,250,000 | |
| Funding Only Action | $1,041,290 | |
| Funding Only Action | $1,640,000 | |
| Funding Only Action | $1,179,000 | |
| Funding Only Action | $1,392,000 | |
| Funding Only Action | $2,576,000 | |
| Funding Only Action | $1,150,000 | |
| Funding Only Action | $2,300,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $7,500,000 |
Show all 12
Quick answers
Who was awarded contract W911SR2390012?
W911SR2390012 was awarded to Battelle Memorial Institute by ACC Aberdeen Proving Ground (Army Contracting Command) on May 16, 2023.
How much is contract W911SR2390012 worth?
W911SR2390012's own ceiling is $62,350,640.
Which agency awarded contract W911SR2390012?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2390012, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR2390012 competed?
The extent of competition for W911SR2390012 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV